Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?

OBJECTIVE: Organ transplant recipients receive immunosuppressive regimens to prevent transplant rejection, which put them at increased risk for opportunistic infections like cytomegalovirus (CMV). Ganciclovir and Valganciclovir are mostly used to prevent or treat CMV. Any incorrect use of the drug m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozaffar, Maryam, Shahidi, Shahrzad, Mansourian, Marjan, Badri, Shirinsadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167560/
https://www.ncbi.nlm.nih.gov/pubmed/30319817
http://dx.doi.org/10.1155/2018/8414385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167560/
https://www.ncbi.nlm.nih.gov/pubmed/30319817
http://dx.doi.org/10.1155/2018/8414385

Ejemplares similares